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Abstract: Foot care prevention programs can reduce the occurrence of foot ulcerations and amputations. This 
investigation evaluated Effectiveness of Semmes–Weinstein monofilament examination for diabetic peripheral 
neuropathy screening in Ahvaz, Iran. In this quasi-experimental design 150 patients with diabetes mellitus were 
recruited by purposive sampling. All patients were tested for sensory neuropathy using Semmes-Weinstein 
Monofilament Examination. In the next phase nerve conduction velocity was examined. The sensitivity of Semmes-
Weinstein Monofilament 10 g was 38.5-61.5% at sites 1-8, whereas the specificity was 77.5-95.5%. Monofilament 
was found to be simple, cheap and useful method and suitable for detection of sensory neuropathy in clinical 
examinations. Hence, we recommend screening of patients for neuropathy as soon as they are diagnosed with 
diabetes.  
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1. Introduction 
Diabetic Peripheral Neuropathy (DPN) is 
one of the most prevalent Complications of diabetes 
mellitus (DM), which can lead to noticeable 
morbidity and mortality, foot ulcers and amputation 
among the diabetic patients (Harklessa et al. 2006, 
Nather et al. 2008). Hence, the identification of 
individuals who are prone to neuropathy would result 
in a decrease in amputation and morbidity (Boyko et 
al. 1999, Levin 1996, Pliskin et al. 1994). Studies 
have shown that 11 percent of patients suffer from 
neuropathy when being diagnosed to have DM and 
Fifty percent of patients with DM are afflicted with it 
after 25 years suffering from the disease. More than 
50000 amputations take place annually in the USA, 
for which the peripheral neuropathy is responsible in 
85 percent of cases (Pham et al., 2000, Pop-Busui et 
al., 2007). 
DPN is not always obvious clinically and it 
has a sub-clinical state in most cases. Therefore, if a 
given physician just suffices to mental symptoms 
during the routine checkups, the diagnosis of DPN 
would be inevitably delayed which would 
accordingly influence the treatment and prognosis of 
the disease (Kamei et al. 2005). 
Diabetic neuropathy affects the patients’ 
quality of life and prognosis of the disease. In 
addition, it can lead to sudden death, orthostatic 
hypotension, and lower limb amputation. In other 
words, recovery from these complications can be 
attained through early screening and diagnosis of 
DPN. Also, diagnosing sensory neuropathy among 
patients helps us to give them comprehensive training 
about taking care of foot and manner of wearing 
shoes so that the progression of diabetic foot 
complication would be hampered by doing such 
interventions (Nather et al. 2008). Thus, early 
diagnosis and treatment of DPN is critical when 
doing outpatient checkups. According to the 
American Diabetics Association (1996), the 
diagnosis of DPN requires the follow-up of these 
cases: a) clinical manifestations, b) clinical 
examinations, c) electro-diagnostic studies, d) 
sensory tests, and e) autonomic performance tests 
(Nather et al. 2008). Nonetheless, conducting electro-
diagnostic studies, including nerve conduction tests 
or electromyography as screening tests at outpatient 
settings are difficult and expensive. So, the diagnosis 
of DPN is carried out by combining 4 of the 5 
aforementioned methods. Among the quantitative 
sensory tests, the old and new monofilaments 
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including the Semmes-Weinstein Monofilament 
Examination (SWME) alongside other sensory tests 
have attracted a lot of attention as appropriate, 
accessible and cheap methods for early screening of 
DPN(Abbott et al. 2002, Dimitrakoudis and Bril 
2002, Dyck et al. 2000, Perkins and Bril 2003, 
Tesfaye et al. 1996, Valk et al. 2000). 
This test is a simple method which is used 
for identifying the amount of sensory neuropathy and 
predicting the likelihood of having diabetic foot 
ulcers in patients with DM so that the costs and 
complications that are imposed on the society due to 
this disease would be minimized.  
Although by virtue of sensation it is easy to 
use SWM, the use of this test has yielded different 
results in different parts of the world. However, no 
universal standard instruction does exist with regard 
to how and where to use the monofilaments or 
interpret their results. As the SWM is the best option 
for clinical diagnosis due to being cheap and safe and 
being able to predict the likelihood of having the risk 
of diabetic foot ulcers or the consequent amputation 
and the reduction of psychological problems 
followed by an early diagnosis among susceptible 
patients alongside the increase in the quality of life 
(Modawal et al. 2006, Rahman et al. 2003), and 
considering the novelty of this method in our country, 
we decided to determine the sensitivity and 
specificity of SWM in patients referring to the 
Diabetic Clinic of Golestan Hospital in Ahvaz,Iran.  
2. Material and Methods  
A quasi-experimental design and purposive 
sampling were conducted. This research was 
conducted from 2009 to 2010 on 150 patients 
suffering from DM, type II, without the diabetic foot 
ulcers who had referred to the Diabetes Clinic of 
Golestan Hospital in Ahvaz. 
The research sample was determined 
through purposive sampling by suing the following 
statistical formula: 
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In this formula which has been adopted from 
previous studies, the amounts are   05.0  ،
2.0   ، 86.01 p   ، 96.02 p (Miranda-
palma  et al. 2005). 
The patients who had the following criteria 
entered the study: (a) Patients who had a stable 
clinical situation and were able to cooperate with the 
researcher, (b) Patients who were able to have verbal 
communication, (c) those who were interested to 
participate in the study. 
The patients, who had the following 
conditions, were excluded from the study: (a) patients 
who suffered from psychological problems, (b) 
patients who had the history of neuropathy due to 
other reasons like hereditary-acquired neuropathy or 
Guillain-Barré Syndrome, (c) pregnant women, (d) 
patients who had the history of brain stroke, (e) 
patients who had callous or any other complications 
in their feet, (f) and patients who were under 
neuropathy treatment 
The 5.07 gram Semmes- Weinstein Monofilament 
Test 
The monofilament test was conducted on the 
patients’ both feet of by two researchers who had 
received the required training about the application of 
the monofilament under the supervision of an 
endocrinologist. This test was done at eight points in 
each foot (the dorsal aspect of the first, second, third, 
fourth, and fifth digits; the dorsal aspect of medial, 
central, and lateral aspect of mid foot) by the 
monofilament Semmes- Weinstein (5.07/10g). The 
way of doing the test was as follows: 
The monofilament was accidentally placed 
on palm of patient's hand while his/her eyes were 
closed and the patient answered the following 
questions: 
- Do you feel the monofilament placed at your 
palm? 
- Which part of your hand is touched by the 
monofilament? 
After making sure about this point that the 
patient has understood the manner of doing and 
responding the questions, we tested the 
monofilaments on the sole of both feet while the 
patient had closed his/her eyes. 
1- The monofilament was placed on the 
patient's skin on which there was no callus and it was 
pressed to the extent that it was bent. 2) The patient 
was asked if s/he feels something on the foot sole; in 
which part of the foot is that sensation felt: left or 
right. 3) The test was repeated three times for each 
point. 4) If the patient answered wrongly two or more 
times after three rounds of tests on any given point, 
that point was recorded as positive. 5) These acts 
were repeated for other points too (Forouzandeh et al. 
2005, Kamei et al. 2005, Mayfield and Sugarman 
2000, Modawal et al. 2006). Both feet were tested for 
5 to 10 minutes. The total time for implementing the 
intervention lasted for 8 months which started in 
November, 2009 and finished in June, 2010.  
Diagnostic Criteria for DPN: In order to 
diagnose the diabetic neuropathy, the nerve 
conduction velocity (standard test) was also done. 
The doer of the nerve conduction velocity was quite 
blind about the clinical examination. For identifying 
the sensitivity and specificity, the results of the 
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monofilament examination were compared with the 
nerve conduction velocity as the gold test. The neural 
conduction tests have been recommended by medical 
studies as the gold test for assessing and validating 
the screening tests of diabetic neuropathy 
(Forouzandeh et al. 2005, Mason et al. 1999, Shin et 
al. 2000). 
The neuropathy was approved through 
conducting the neural conduction test which was 
done by a neurologist when there was disturbance in 
two or more nerves and in symmetrical mode. The set 
applied here for taking neuromuscular graph was the 
Biomed, model 3520 belonging to the Negar 
Andisheh Company. 
Data analysis: The data analysis was 
performed using the SPSS software Ver.16. The 
Sensitivity and specificity of the SWME were 
measured. The data were presented as means and 
standard deviations, and percentiles. 
Ethical Considerations: After the approval of the 
study at the Ethics Committee of Jundishapur 
Medical Sciences University, Ahvaz, Iran, informed 
consent was taken from the patients for participating 
in the study. Also, the patients received enough 
information about the safety of this method and their 
freedom for entering into or exiting the study. 
 
3. Results  
Among 150 patients participating in the 
study, there were 47 male (31.3%) and 103 female 
(68.7%). The average age of the patients was 55.71 
years (SD= 8.95 years) and the mean of their disease 
duration was 7.7 years (SD = 6.1 years). We assessed 
sensitivity and specificity of 10-g monofilament in 
terms of neuropathy trace as follows: 
At least one point out of 16 points on both 
feet should be reported as insensate; at a minimum, 
two points out of 16 points on both feet should be 
reported as insensate; no less than 8 points out of 16 
points on both feet should be reported as insensate. 
We found that the sensitivities of the monofilament 
ranged from 38.5 to 61.5 % while the specificities 
ranged from 77.5 to 95.5 percent (Tables 1-2). 
 
 
Table 1. Sensitivity and specificity of 10 g monofilament according to the number of insensate 
 specificity Sensitivity Testing site  
77.5 61.5 Semmes-weinstein 10g≥1/16 
79.3 59 Semmes-weinstein 10g≥2/16 
95.5 38.5 Semmes-weinstein 10g≥8/16 
   
Data are %  
 
Table 2. The sensitivities of the monofilament 
patients EMG-NCV Semmes-weinstein 10 gr 
abunda
nce 
percentile abundance percentile 
One point*     
neuropathy 39 26 20 13 
No- 
neuropathy 
111 74 130 87 
total 150 100 150 100 
Two points†     
neuropathy 39 26 18 12 
No- 
neuropathy 
111 74 132 88 
total 150 100 150 100 
Eight points ‡     
neuropathy 39 26 15 10 
No- 
neuropathy 
111 74 135 90 
total 150 100 150 100 
* Cutoffs of ≥1 insensate sites of 16 
 †Cutoffs of ≥2 insensate sites of 16  
‡ Cutoffs of ≥8 insensate sites of 16 
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4. Discussions  
We applied the Semmes-Weinstein 
monofilament at eight points on each foot in this 
study. This test is one of the most important tests in 
clinical examination. The sensitivity of this test was 
38.5-61.5 % and its specificity was 77.5-95.5% in 
screening the diabetic neuropathy. The almost 
moderate sensitivity indicates that unusual cases and 
numb points can be diagnosed only in highly severe 
neuropathy. The use of this test in our study showed 
that the Semmes-Weinstein 10 gram monofilament 
can be effective in tracing and screening the 
decreased of protective sense of diabetic foot. 
Nonetheless, those complications which are often 
something impossible to be diagnosed with reflexive 
or vibrating tests are barely diagnosed by the 
monofilament test. So, using this test alongside the 
above methods is more effective in screening the 
neuropathic cases. Other studies also recommended 
that the likelihood of screening and early diagnosis of 
peripheral neuropathy by using a mixture of different 
methods, especially a combination of monofilament 
with clinical examinations or clinical symptoms or 
sensory tests is a little increased (Abouaesha et al. 
2001, Olmos et al. 1995). 
Nozomu kamei (2005) tested the sensitivity 
and specificity of two types of monofilaments, 
through which the sensitivity and specificity of the 
SWM 10 gram was 30% and 92%, respectively. This 
amount was lower with respect to the sensitivity of 
monofilament in our study but higher with regard to 
its specificity which can be attributed to the number 
of samples, type of sampling and other characteristics 
of patients, including the level of HbA1c, controlling 
of diet and duration of DM, medications regiments 
(Kamei et al. 2005). 
We got a sensitivity and specificity of 38.5-
61.5% and 77.5-95.5% for the Semmes-Weinstein 10 
gram monofilament. However, a sensitivity and 
specificity of 32.5-47.5% and 73.8-92.9%  (Dyck et 
al. 2000, Valk et al. 2000) and 65-86% and 58-71%  
(Abbott et al. 2002, Dimitrakoudis and Bril 2002) 
have been reported in other studies. 
The prevalence of diabetic neuropathy has 
been between 9.33 to 14 percent based on the 
positive results of the SWMF 10 gram. These 
findings are different from other studies' findings, 
including Foruzandeh's study, in which the 
prevalence of diabetic neuropathy was 23.9 percent 
based on the positive results of the monofilament test. 
This discrepancy can be due to the number of 
samples participating in the study, the type of 
sampling and the number of examined points 
(Forouzandeh et al. 2005). 
Considering this point that the monofilament 
test has been used a lot for tracing neuropathy 
recently, no definite information exists about the 
optimal use of this test for screening the numbness of 
foot and accordingly the diabetic foot ulcers. 
Although lots of studies have used monofilaments for 
screening purposes, no precise data is available about 
the application of a standard method for 
monofilament up to now (Mayfield and Sugarman 
2000). 
A limitation with this study, the number of 
participants in this study was relatively small and a 
prospective study with sufficient power is performed 
to compare monofilament with other testing 
modalities, definitive conclusions cannot be drawn. 
 
Conclusion 
The use of monofilament alone or alongside 
with other methods and criteria for screening 
neuropathy is an easy, useful and accessible way. 
Following due diagnosis, therapeutic measures and 
required trainings, this method can prevent the great 
number of complications of neuropathy, especially 
ulcers and amputation of the diabetic foot.  
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